Abstract
Background: The use of class III antiarrhythmic drugs (ADIII) has been considered a good predictor of sinus rhythm in patients post‐cardioversion from atrial fibrillation (AF). Several studies using frequency domain analysis of signal‐averaged ECG (FDSAECG) of the P wave were able to identify patients at risk for AF. The aim of this study was to assess the FDSAECG in predicting recurrence of idiopathic persistent AF (IPAF) in patients under ADIII therapy.
Methods: In 33 patients with two or more previous symptomatic episodes of IPAF, despite classes I and II therapy, the FDSAECG of the P wave was performed during sinus rhythm and free‐drug state. The parameters were the mean and standard deviation of the frequency intersegmentar spectral correlation and the standard deviation of the signal frequency edge track. During the follow‐up of 30 ± 18 months, all patients received either amiodarone or sotalol.
Results: During the follow‐up, the patients were divided into two groups: Group I—frequent recurrence (≧ three events/year; 16 patients), and Group II—infrequent recurrence (< three events/ year; 17 patients). With appropriate cutoff points for each parameter analyzed, intense fragmented electrical activity defined by the presence of at least two abnormal criteria were observed in 13 of 16 patients group I and in 3 of 17 patients group II (P = 0.0003). Sensitivity, specificity, positive and negative predictive values for frequent recurrence were 81.3, 82.4, 81.3, and 82.4, respectively.
Conclusions: The results suggested that FDSAECG analysis of the P wave accurately predicted patients whose ADIII therapy will be effective in maintaining the sinus rhythm without frequent recurrence of IPAF. A.N.E. 2001;6(1):43–49
Keywords: signal‐averaged ECG, P wave, idiopathic atrial fibrillation, spectral‐temporal mapping, antiarrhythmic therapy
REFERENCES
- 1. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 1982;306: 1018–1022. [DOI] [PubMed] [Google Scholar]
- 2. Halperin JL, Hart RG. Atrial fibrillation and stroke: New Ideas, persisting dilemmas. Stroke 1988;19:937–941. [DOI] [PubMed] [Google Scholar]
- 3. Krahn AD, Manfreda J, Tait RB, et al. The natural history of atrial fibrillation. Incidences, risk factors and prognosis of atrial fibrillation in the Manitoba Follow‐up Study. Am J Med 1995;98: 476–484. [DOI] [PubMed] [Google Scholar]
- 4. Repique LJ, Shah SN, Morais GE. Atrial fibrillation 1992: Management strategies in flux. Chest 1992;101:1095–1103. [DOI] [PubMed] [Google Scholar]
- 5. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. A population‐based study over 3 decades. N Engl J Med 1987;317: 669–674. [DOI] [PubMed] [Google Scholar]
- 6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983. [DOI] [PubMed] [Google Scholar]
- 7. Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation. 30‐year follow‐up in the Framingham Study. JAMA 1985;254: 3449–3453. [PubMed] [Google Scholar]
- 8. Rostagno C, Olivo G, Comeglio M, et al. Left atrial size changes in patients with paroxysmal lone atrial fibrillation. An echocardiographic follow‐up. Angiology 1996;47: 797–801. [DOI] [PubMed] [Google Scholar]
- 9. Suttorp MJ, Kingma JH, Koomen EM, et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993;71:710–713. [DOI] [PubMed] [Google Scholar]
- 10. Duytschever M, Hearynck F, Tavernier R, et al. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion from atrial fibrillation. PACE 1998;21:284–287. [DOI] [PubMed] [Google Scholar]
- 11. Rosenheck S. Signal‐averaged P wave in patients with paroxysmal atrial fibrillation. PACE 1997;20:2577–2586. [DOI] [PubMed] [Google Scholar]
- 12. Ehlert FA, Steinberg JS. The P wave signal‐averaged ECG. J Electrocardiol 1995;28(Suppl.):33–38. [DOI] [PubMed] [Google Scholar]
- 13. Cain ME, Ambos HD, Witkowski FX, et al. Fast Fourier transform analysis of signal‐averaged electrocardiograms for identification of patients prone to sustained ventricular tachycardia. Circulation 1984;69:711–720. [DOI] [PubMed] [Google Scholar]
- 14. Lindsay BD, Markham J, Schechtman KB, et al. Identification of patients with sustained ventricular tachycardia by frequency analysis of signal‐averaged electrocardiograms despite the presence of bundle branch block. Circulation 1988;77:122–130. [DOI] [PubMed] [Google Scholar]
- 15. Buckingham TA, Thessen CM, Hertweck D, et al. Signal‐averaged electrocardiography in the time and frequency domains. Am J Cardiol 1989;63:820–825. [DOI] [PubMed] [Google Scholar]
- 16. Barbosa EC, Barbosa PRB, Ginefra P, et al. Frequency domain analysis of the signal‐averaged electrocardiogram. Application of statistical techniques of spectral correlation for identification of patients with sustained monomorphic ventricular tachycardia. Arq Bras Cardiol 1998;71: 595–599. [DOI] [PubMed] [Google Scholar]
- 17. Kelen GJ, Henkin R, Starr AM, et al. Spectral turbulence analysis of the signal‐averaged electrocardiogram and its predictive accuracy for inducible sustained monomorphic ventricular tachycardia. Am J Cardiol 1991;67:965–975. [DOI] [PubMed] [Google Scholar]
- 18. Buxton AE, Waxman HL, Marchlinsk FE, et al. Atrial conduction: Effects of extrastimuli with and without atrial dysrhythmia. Am J Cardiol 1984;54:755–761. [DOI] [PubMed] [Google Scholar]
- 19. Josephson ME. Atrial flutter and fibrillation, in Josephson ME. (ed): Clinical Cardiac Electrophysiology Techniques and Interpretations. Philadelphia , Lea & Febiger, 1992;pp. 275–310. [Google Scholar]
- 20. Simpson RJ, Amara I, Foster JR, et al. Thresholds, refractory periods, and conduction times of the normal and disease human atrium. Am Heart J 1988;116:1080–1090. [DOI] [PubMed] [Google Scholar]
- 21. Kyle RAE, Grip PR. Amyloidosis (AL), clinical and laboratory features in 229 cases. Mayo Clin Proc 1983;58:665–683. [PubMed] [Google Scholar]
- 22. Frustaci A, Chiment C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180–1184. [DOI] [PubMed] [Google Scholar]
- 23. Bustos D, Perrenoud JJ, Michel JP, et al. Postmortem diagnosis of cardiac amyloidosis in the aged. Anatomoctinical correlation. Arch Mal Coeur Vaiss 1993;83: 315–319. [PubMed] [Google Scholar]
- 24. Yamada T, Fukunami M, Ohmori M, et al. Characteristics of frequency content of atrial signal‐averaged electrocardiograms during sinus rhythm in patients with paroxysmal atrial fibrillation. J Am Col Cardiol 1992;19:559–563. [DOI] [PubMed] [Google Scholar]
- 25. Hiraki T, Ikeda H, Ohga M, et al. Frequency‐and time‐domain analysis of P wave in patients with paroxysmal atrial fibrillation. PACE 1998;21:56–64. [DOI] [PubMed] [Google Scholar]
- 26. Stafford P, Denbigh P, Vincent R. Frequency analysis of the P Wave: Comparative techniques. PACE 1995;18:261–270. [DOI] [PubMed] [Google Scholar]
- 27. Barbosa EC, Barbosa PRB, Ginefra P, et al. Frequency analysis of the signal‐averaged ECG of the P wave for identification of patients at risk of recurrence of idiopathic atrial fibrillation. J Am Coll Cardiol 1998;31(Suppl. C):40. [Google Scholar]
- 28. Stafford PJ, Vincent R. Spectrotemporal and spectral turbu lence analysis of the signal‐averaged P wave in paroxysmal atrial fibrillation. J Electrocardiol 1997;30:79–86. [DOI] [PubMed] [Google Scholar]
- 29. Michelucci A, Padaletti L, Chelucci A, et al. Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P Wave triggered SAECG in patients with lone atrial fibrillation. PACE 1996;19:758–767. [DOI] [PubMed] [Google Scholar]
- 30. Kumagai K, Akimitsu S, Kawanami F, et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991;84:1662–1668. [DOI] [PubMed] [Google Scholar]
- 31. Chun SH, Sager PT, Stevenson WG, et al. Long‐term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flut ter. Am J Cardiol 1995;76:47–50. [DOI] [PubMed] [Google Scholar]
- 32. Turitto G, Bandarizadeh B, Salciccioli L, et al. Risk stratin cation for recurrent tachyarrhythmias in patients with paroxysmal atrial fibrillation and flutter: Role of signal aver aged electrocardiogram and echocardiography. PACE 1998. 21:197–201. [DOI] [PubMed] [Google Scholar]
- 33. Hohnloser SH, Van de Loo A, Baedeker F, et al. Efficacy and safety of sotalol versus quinidine for the conversion of persistent atrial fibrillation. A prospective randomized comparison. Circulation 1993;88:I–65. [Google Scholar]
- 34. Reimold SC, Cantillon CO, Friedman PL, et al. Propafenone versus sotalol for suppression of recurrence symptomatic atrial fibrillation. Am J Cardiol 1993;71:558–563. [DOI] [PubMed] [Google Scholar]
- 35. Fitton A, Sorkin EM. Sotalol, An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias. Drugs 1993;46:678–719. [DOI] [PubMed] [Google Scholar]
- 36. Kerr C, Boone J, Connolly S, et al. The initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J 1996;17(Suppl C):48–51. [DOI] [PubMed] [Google Scholar]
- 37. Gosselink AT, Crijns HJ, Van Gelder IC, et al. Low‐dose amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation or flutter. JAMA 1992;267:3289–3293. [PubMed] [Google Scholar]